1. Home
  2. DNP vs TMDX Comparison

DNP vs TMDX Comparison

Compare DNP & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DNP Select Income Fund Inc.

DNP

DNP Select Income Fund Inc.

HOLD

Current Price

$10.05

Market Cap

3.8B

Sector

Finance

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$136.66

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNP
TMDX
Founded
1986
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
DNP
TMDX
Price
$10.05
$136.66
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$133.00
AVG Volume (30 Days)
479.6K
835.5K
Earning Date
01-01-0001
10-29-2025
Dividend Yield
7.88%
N/A
EPS Growth
N/A
170.70
EPS
2.30
2.54
Revenue
$154,887,179.00
$566,354,000.00
Revenue This Year
N/A
$38.84
Revenue Next Year
N/A
$20.43
P/E Ratio
$4.26
$53.83
Revenue Growth
3.30
41.20
52 Week Low
$8.69
$55.00
52 Week High
$10.04
$156.00

Technical Indicators

Market Signals
Indicator
DNP
TMDX
Relative Strength Index (RSI) 46.06 54.31
Support Level $10.00 $133.50
Resistance Level $10.35 $156.00
Average True Range (ATR) 0.11 8.50
MACD -0.02 0.41
Stochastic Oscillator 14.29 55.98

Price Performance

Historical Comparison
DNP
TMDX

About DNP DNP Select Income Fund Inc.

DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: